Molecular and virulence differences of Klebsiella pneumoniae isolated from blood

Zhaoxia Xu1, Yuxuan Xiong2, Xueguang Duan1

  • 1Department of Clinical Laboratory, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China.

PubMed
Abstract

Insights

Klebsiella pneumoniae bloodstream infections show significant diversity in drug resistance and virulence. Understanding these differences is key to effective patient treatment and combating this public health threat.

Area of Science:

  • Microbiology
  • Genomics
  • Infectious Diseases

Background:

  • Bloodstream infections (BSIs) with Klebsiella pneumoniae (K. pneumoniae) sepsis pose a life-threatening public health risk.
  • Increasing reports of K. pneumoniae isolates in China necessitate further investigation.
  • A case-based genomic and experimental study was conducted to understand patient-specific K. pneumoniae diversity.

Purpose of the Study:

  • To investigate the diversity of K. pneumoniae strains isolated from blood cultures in patients with sepsis.
  • To differentiate K. pneumoniae isolates based on genetic type, serotype, virulence factors, and antimicrobial resistance (AMR) profiles.
  • To correlate molecular characteristics with patient outcomes.

Main Methods:

  • Whole genome sequencing (WGS) and antimicrobial susceptibility testing were performed on six K. pneumoniae isolates from patients between January 2022 and April 2023.
  • Analysis included determination of serotype, molecular subtype, virulence-associated genes, AMR genes, and plasmid content.
  • Experimental models were used to assess the virulence of hypervirulent K. pneumoniae (hvKp) isolates.

Main Results:

  • WGS revealed five distinct genetic types among the six isolates, including three carbapenem-resistant (CRKp) and two hypervirulent (hvKp) K. pneumoniae strains.
  • CRKp isolates exhibited resistance to most antibiotics, carried multiple resistance plasmids, and harbored the KPC-2 gene on different plasmids.
  • HvKp isolates, while susceptible to all tested antimicrobials, showed a higher mortality rate in mice, indicating significant virulence despite fewer resistance genes.

Conclusions:

  • Significant diversity exists in drug resistance genes, virulence factors, and plasmids among K. pneumoniae strains from different patients within the same hospital.
  • These molecular differences can impact patient outcomes.
  • Tailoring patient treatment based on the molecular characteristics and drug resistance phenotype of K. pneumoniae isolates is crucial for improving therapeutic efficacy.